APR-2020

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameAPR-2020
Drug Alias NameAPR-2020
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsAnemia, Diamond-Blackfan
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesApriligen Inc
China Registration ClassN/A

Develop Information

Active CompaniesApriligen Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Diamond-Blackfan
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A